298 related articles for article (PubMed ID: 32883537)
41. [Gender and age factors affecting the mortality during the COVID-19 epidemic in Italy].
Azzolina D; Magnani C; Gallo E; Ferrante D; Gregori D
Epidemiol Prev; 2020; 44(5-6 Suppl 2):252-259. PubMed ID: 33412817
[TBL] [Abstract][Full Text] [Related]
42. Monocyte absolute count as a preliminary tool to distinguish between SARS-CoV-2 and influenza A/B infections in patients requiring hospitalization.
Curtolo A; Oliva A; Volpicelli L; Ceccarelli G; D'Ettorre G; Borrazzo C; Mastroianni CM; Venditti M
Infez Med; 2020 Dec; 28(4):534-538. PubMed ID: 33257627
[TBL] [Abstract][Full Text] [Related]
43. SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic.
Canetti D; Dell'Acqua R; Riccardi N; Della Torre L; Bigoloni A; Muccini C; Bruzzesi E; Ranzenigo M; Chiurlo M; Racca S; Galli C; Castagna A; Tambussi G; Lazzarin A
New Microbiol; 2020 Oct; 43(4):161-165. PubMed ID: 33135083
[TBL] [Abstract][Full Text] [Related]
44. Adrenal Insufficiency at the Time of COVID-19: A Retrospective Study in Patients Referring to a Tertiary Center.
Carosi G; Morelli V; Del Sindaco G; Serban AL; Cremaschi A; Frigerio S; Rodari G; Profka E; Indirli R; Mungari R; Resi V; Orsi E; Ferrante E; Dolci A; Giavoli C; Arosio M; Mantovani G
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1354-e1361. PubMed ID: 33107576
[TBL] [Abstract][Full Text] [Related]
45. Le disuguaglianze di accesso ai programmi di screening dei tumori della mammella, del colon retto e della cervice uterina sono aumentate durante il periodo pandemico. Risultati di un health equity audit condotto dall'Agenzia di Tutela della Salute d.
Girardi D; Vecchio R; Tanious M; Cacitti S; Ancarani C; Dalle Carbonare S; Perotti P; Bonafede C; Cavallo R; Gentile L; Parrini A; Lucente EM; Carlesso A; Cadum E; Cecconami L; Odone A; Deandrea S
Epidemiol Prev; 2024; 48(2):130-139. PubMed ID: 38770730
[TBL] [Abstract][Full Text] [Related]
46. Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy.
De Vito A; Geremia N; Fiore V; Princic E; Babudieri S; Madeddu G
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7861-7868. PubMed ID: 32744714
[TBL] [Abstract][Full Text] [Related]
47. Prediction of in-hospital mortality of patients with SARS-CoV-2 infection by comorbidity indexes: an Italian internal medicine single center study.
De Giorgi A; Fabbian F; Greco S; Di Simone E; De Giorgio R; Passaro A; Zuliani G; Manfredini R;
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10258-10266. PubMed ID: 33090437
[TBL] [Abstract][Full Text] [Related]
48. SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry.
Gonzalez-Cao M; Puertolas T; Martinez-Vila C; Carrera C; Maldonado Seral C; Rodríguez-Jiménez P; Sequero S; Cerezuela-Fuentes P; Feltes Ochoa R; Muñoz E; Antoñanzas Basa M; Martín-Liberal J; Soria A; Francisco Rodriguez Moreno J; Marquez-Rodas I; Lopez Criado P; Luis Manzano J; Lopez-Castro R; Ayala de Miguel P; Villalobos L; Martin Algarra S; Gonzalez-Barrallo I; Boada A; García Castaño A; Puig S; Crespo G; Luna Fra P; Aguayo Zamora C; Feito Rodríguez M; Valles L; Drozdowskyj A; Gardeazabal J; Antonio Fernandez-Morales L; Rodrigo A; Cruz R; Yelamos O; Rubio B; Mujica K; Provencio M; Berrocal A;
Clin Transl Oncol; 2023 Mar; 25(3):768-775. PubMed ID: 36566266
[TBL] [Abstract][Full Text] [Related]
49. Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19.
Corsini Campioli C; Cano Cevallos E; Assi M; Patel R; Binnicker MJ; O'Horo JC
J Clin Virol; 2020 Sep; 130():104577. PubMed ID: 32777762
[TBL] [Abstract][Full Text] [Related]
50. Clinical characteristics of individuals with Down syndrome deceased with CoVID-19 in Italy-A case series.
Villani ER; Carfì A; Di Paola A; Palmieri L; Donfrancesco C; Lo Noce C; Taruscio D; Meli P; Salerno P; Kodra Y; Pricci F; Tamburo de Bella M; Floridia M; Onder G;
Am J Med Genet A; 2020 Dec; 182(12):2964-2970. PubMed ID: 32918520
[TBL] [Abstract][Full Text] [Related]
51. Health-care organization for the management and surveillance of SARS-CoV-2 infection in children during pandemic in Campania region, Italy.
Nunziata F; Bruzzese E; Poeta M; Pierri L; Catzola A; Ciccarelli GP; Vassallo E; Montella E; Lo Vecchio A; Guarino A
Ital J Pediatr; 2020 Nov; 46(1):170. PubMed ID: 33198780
[TBL] [Abstract][Full Text] [Related]
52. Clinical and epidemiological profile of patients infected by COVID-19 at a tertiary care centre in North India.
Prakash S; Agrawal MM; Kumar R; Yadav S
Monaldi Arch Chest Dis; 2020 Nov; 90(4):. PubMed ID: 33305553
[TBL] [Abstract][Full Text] [Related]
53. Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean.
Mattar S; Martinez-Bravo C; Rivero R; Contreras H; Faccini-Martínez ÁA; Guzman-Teran C; Galeano K; Alvis-Guzman N; Contreras V; Arrieta G; Gonzalez-Tous M; Miranda J; Ospina M; Camargo-Assis F; Mercado-Reyes M; Garay E; Garcia-Perez A; Lopez Y; Tique V
Ann Clin Microbiol Antimicrob; 2020 Dec; 19(1):58. PubMed ID: 33287846
[TBL] [Abstract][Full Text] [Related]
54. A significant reduction in the diagnosis of melanoma during the COVID-19 lockdown in a third-level center in the Northern Italy.
Barruscotti S; Giorgini C; Brazzelli V; Vassallo C; Michelerio A; Klersy C; Chiellino S; Tomasini CF
Dermatol Ther; 2020 Nov; 33(6):e14074. PubMed ID: 32713046
[No Abstract] [Full Text] [Related]
55. Effects of the COVID-19 pandemic on care of melanoma patients in Berlin, Germany: the Mela-COVID survey.
Teuscher M; Diehl K; Schaarschmidt ML; Weilandt J; Sasama B; Ohletz J; Könnecke A; Harth W; Hillen U; Peitsch WK
Eur J Dermatol; 2022 Jul; 31(4):521-529. PubMed ID: 36094385
[TBL] [Abstract][Full Text] [Related]
56. COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy.
Calza L; Bon I; Tadolini M; Borderi M; Colangeli V; Badia L; Verucchi G; Rossini G; Vocale C; Gaibani P; Viale P; Attard L
Infection; 2021 Apr; 49(2):333-337. PubMed ID: 32748333
[TBL] [Abstract][Full Text] [Related]
57. Challenges of Cancer Immunotherapy during the COVID-19 Pandemic.
Kuderer NM; Lyman GH
Cancer Invest; 2021 Feb; 39(2):115-119. PubMed ID: 33356638
[No Abstract] [Full Text] [Related]
58. Impact of the COVID-19 Pandemic on Treatment and Oncologic Outcomes for Cancer Patients in Romania.
Trifanescu OG; Gales L; Bacinschi X; Serbanescu L; Georgescu M; Sandu A; Michire A; Anghel R
In Vivo; 2022; 36(2):934-941. PubMed ID: 35241552
[TBL] [Abstract][Full Text] [Related]
59. Impact of COVID-19 pandemic on patients with Fabry disease: An Italian experience.
Riccio E; Pieroni M; Limoneglli G; Pisani A
Mol Genet Metab; 2020; 131(1-2):124-125. PubMed ID: 32741663
[TBL] [Abstract][Full Text] [Related]
60. The Impact of SARS-CoV-2 Pandemic on Patients with Malignant Melanoma at a Romanian Academic Center: A Four-Year Retrospective Analysis.
Aabed H; Bloanca V; Crainiceanu Z; Bratosin F; Citu C; Diaconu MM; Ciorica O; Bratu T
Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
